Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
2 studies found for:    21709064 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Active, not recruiting A Study of Genetically Targeted Enzyme Replacement Therapy for Advanced Heart Failure
Conditions: Ischemic Cardiomyopathy;   Non-ischemic Cardiomyopathy;   Heart Failure;   Cardiomyopathies
Interventions: Genetic: AAV1/SERCA2a (MYDICAR);   Genetic: Placebo
2 Completed
Has Results
Efficacy and Safety Study of Genetically Targeted Enzyme Replacement Therapy for Advanced Heart Failure
Conditions: Heart Failure, Congestive;   Dilated Cardiomyopathy
Interventions: Genetic: MYDICAR Phase 1 (Open-label, Serial Dose-Escalation Study);   Procedure: Placebo Infusion;   Genetic: MYDICAR Phase 2 (Placebo-controlled, Randomized Study)

Indicates status has not been verified in more than two years